As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.

The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.

For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit (angela.steinbach@uk-koeln.de or vassiliki.dimitriou@uk-koeln.de).

EUROSIDA

AcronymISRCTNEudraCTNCT (clinicaltrials.gov)DRKS

EUROSIDA Kohorte

Status: Active

Purpose / Objectives

Primary Outcome

database

Secondary Outcomes

na

Diagnosis

HIV

Target population

Stage

HIV

Age

18-99

Inclusion criteria

NA

Exclusion criteria

na

Study design

  • Multicenter
  • Retrospective

Intervention

na

Documents (password protected)

Responsibilities in overall study

CHIP Kopenhagen

  • Tel. +45 35 45 5757
  • Fax +45 35 45 5758

National Coordinating Investigator

Univ.-Prof. Dr. med. Gerd Fätkenheuer